New shot against rift valley fever moves to human safety tests
NCT ID NCT06925919
First seen Apr 10, 2026 · Last updated May 02, 2026 · Updated 4 times
Summary
This early-stage study tests a new medicine called IDB-011 in 40 healthy adults to see if it is safe and how the body processes it. The medicine is designed to prevent Rift Valley Fever, a serious viral disease spread by mosquitoes. Participants receive either the medicine or a placebo and are monitored for side effects and immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RIFT VALLEY FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Los Angeles
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.